Vancomycin Dosing for 55kg Patient with Diabetic Foot Infection and Potential Impaired Renal Function
For a 55kg patient with diabetic foot infection and potential impaired renal function, administer a loading dose of 1375-1650 mg (25-30 mg/kg) regardless of renal function, followed by maintenance dosing of 825-1100 mg (15-20 mg/kg) with the interval extended based on creatinine clearance, and obtain trough levels before the fourth dose targeting 15-20 mg/L. 1
Loading Dose Strategy
- Administer 1375-1650 mg (25-30 mg/kg based on actual body weight of 55kg) as a loading dose, even in the presence of renal dysfunction. 1
- The loading dose is NOT affected by renal impairment and is critical to rapidly achieve therapeutic concentrations, particularly in diabetic foot infections which are serious soft tissue infections. 1
- Infuse the loading dose over at least 1.5-2 hours to minimize infusion-related reactions (red man syndrome), and consider antihistamine premedication for doses exceeding 1 gram. 1, 2, 3
Maintenance Dosing Algorithm
If Creatinine Clearance is Known or Estimated:
- Calculate maintenance dose as 825-1100 mg (15-20 mg/kg) but adjust the INTERVAL based on renal function, not the dose itself. 1
- For creatinine clearance ≥60 mL/min: Give every 8-12 hours 1, 3
- For creatinine clearance 40-60 mL/min: Give every 12-24 hours 3
- For creatinine clearance 20-40 mL/min: Give every 24-48 hours 3
- For creatinine clearance <20 mL/min: Give every 48-72 hours or longer 1, 3
Critical Consideration for Diabetic Foot Infections:
- Diabetic foot infections represent serious soft tissue infections requiring aggressive dosing with target trough levels of 15-20 mg/L. 1, 2
- Patients with diabetic foot infections may have unpredictable vancomycin pharmacokinetics, with volume of distribution potentially differing from population estimates. 4
Therapeutic Monitoring Protocol
- Obtain trough concentration immediately before the fourth dose (at steady state) to guide further dosing adjustments. 1, 5
- Target trough concentration: 15-20 mg/L for this serious infection 1, 2, 5
- The target AUC/MIC ratio is ≥400, which correlates with clinical efficacy. 1, 5
- Monitor serum creatinine closely for nephrotoxicity, defined as increases of ≥0.5 mg/dL or 150% from baseline. 6
Specific Dosing Example for This Patient:
Assuming normal or mildly impaired renal function (CrCl >60 mL/min):
- Loading dose: 1500 mg IV over 2 hours
- Maintenance: 1000 mg IV every 12 hours
- First trough: Before 4th dose (36 hours after starting therapy)
If moderate renal impairment (CrCl 40-60 mL/min):
- Loading dose: 1500 mg IV over 2 hours (unchanged)
- Maintenance: 1000 mg IV every 24 hours
- First trough: Before 4th dose
Critical Pitfalls to Avoid
- Do NOT use fixed 1 gram every 12 hours dosing without weight-based calculation and renal function assessment. 1, 2
- Do NOT skip the loading dose in serious infections, even with renal impairment—only maintenance intervals require adjustment. 1
- Do NOT rely on population nomograms alone in diabetic foot infections, as these patients may have altered pharmacokinetics requiring individualized monitoring. 4
- Do NOT continue therapy if vancomycin MIC is ≥2 mg/L; switch to alternative agents (daptomycin, linezolid, or ceftaroline). 1, 5
- Sustained trough concentrations >20 mg/L significantly increase nephrotoxicity risk, especially with concurrent nephrotoxic agents. 6, 5
Alternative Therapy Considerations
- If the patient is on multiple nephrotoxic medications (aminoglycosides, piperacillin-tazobactam, NSAIDs), consider alternative agents from the outset. 1
- For diabetic foot infections with documented MRSA and MIC ≥2 mg/L, immediately switch to daptomycin or linezolid rather than attempting higher vancomycin doses. 1, 5